Table: Rohto -2025/26 group results

Rohto Pharmaceutical

13/05/2026 07:34

May 13 (Reuters)- 
          Rohto Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2026    Mar 31, 2025   Mar 31, 2027     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            343.73          308.63         369.50                 
                 (+11.4 pct)     (+14.0 pct)    (+7.5 pct)               
  Operating         41.12           38.23          43.80                 
                 (+7.5 pct)      (-4.5 pct)     (+6.5 pct)               
  Recurring         47.97           39.73          46.10                 
                 (+20.8 pct)     (-6.4 pct)     (-3.9 pct)               
  Net
  Net               34.25           30.84          34.50                 
                 (+11.0 pct)     (-0.3 pct)     (+0.7 pct)               
  EPS            151.56 yen      135.38 yen     152.68 yen               
  EPS Diluted    145.29 yen      134.72 yen                              
  Ann Div         46.00 yen       36.00 yen      50.00 yen               
  -Q2 Div         21.00 yen       16.00 yen      25.00 yen               
  -Q4 Div         25.00 yen       20.00 yen      25.00 yen               
  
  NOTE - Rohto Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T